The tanapoxvirus 15L protein is a virus-encoded neuregulin that promotes viral replication in human endothelial cells

Journal of Virology

Volumn 87, Issue 6, 2013, Pages 3018-3026

  Jeng, David ^a   Ma, Zhenzhong ^b   Barrett, John W ^c   McFadden, Grant ^d   Loeb, Jeffrey A ^b   Essania, Karim ^a  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; EPIDERMAL GROWTH FACTOR LIKE GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HEPARIN; IMMUNOGLOBULIN; NEU DIFFERENTIATION FACTOR; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASSAY; BACULOVIRUS EXPRESSION SYSTEM; CELL DIFFERENTIATION; CELL SURVIVAL; CHORDOPOXVIRINAE; CONTROLLED STUDY; ENDOCARDIUM; ENDOTHELIUM CELL; EPITHELIUM; GENE INACTIVATION; HUMAN; MORPHOGENESIS; NEUROMUSCULAR SYNAPSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SCHWANN CELL; TANAPOXVIRUS; UMBILICAL VEIN ENDOTHELIAL CELL; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS REPLICATION; VIRUS VIABILITY; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; ENDOTHELIAL CELLS; GENE KNOCKOUT TECHNIQUES; HUMANS; MOLECULAR SEQUENCE DATA; NEUREGULINS; SEQUENCE ALIGNMENT; VIRAL PROTEINS; VIRULENCE FACTORS; VIRUS REPLICATION; YATAPOXVIRUS;

EID: 84874680784     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02112-12     Document Type: Article

References (49)

1. Schneider MR, Wolf E. 2008. The epidermal growth factor receptor and its ligands in female reproduction: insights from rodent models. Cytokine Growth Factor Rev. 19:173-181.
2. Tzahar E, Moyer JD, Waterman H, Barbacci EG, Bao J, Levkowitz G, Shelly M, Strano S, Pinkas-Kramarski R, Pierce JH, Andrews GC, Yarden Y. 1998. Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network. EMBO J. 17:5948-5963.
3. Burden S, Yarden Y. 1997. Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron 18:847-855.
4. Baulida J, Kraus MH, Alimandi M, Di Fiore PP, Carpenter G. 1996. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. Biol. Chem. 271:5251-5257.
5. Baselga J, Tripathy D, Mendelsohn J, Baughman S, Benz CC, Dantis L, Sklarin NT, Seidman AD, Hudis CA, Moore J, Rosen PP, Twaddell T, Henderson IC, Norton L. 1996. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J. Clin. Oncol. 14:737-744.
6. Wang X, Mizushima H, Adachi S, Ohishi M, Iwamoto R, Mekada E. 2006. Cytoplasmic domain phosphorylation of heparin-binding EGF-like growth factor. Cell Struct. Funct. 31:15-27.
7. Li Q, Esper RM, Loeb JA. 2004. Synergistic effects of neuregulin and agrin on muscle acetylcholine receptor expression. Mol. Cell Neurosci. 26:558-569.
8. Loeb JA, Khurana TS, Robbins JT, Yee AG, Fischbach GD. 1999. Expression patterns of transmembrane and released forms of neuregulin during spinal cord and neuromuscular synapse development. Development 126:781-791.
9. Pankonin MS, Gallagher JT, Loeb JA. 2005. Specific structural features of heparan sulfate proteoglycans potentiate neuregulin-1 signaling. J. Biol. Chem. 280:383-388.
10. Jeng D, Rahman MM, McFadden G, Essani K. 2011. Tumor necrosis factor inhibitors from poxviruses with an emphasis on tanapoxvirus-2L protein. Recent Pat. DNA Gene Seq. 5:97-103.
11. Seet BT, Johnston JB, Brunetti CR, Barrett JW, Everett H, Cameron C, Sypula J, Nazarian SH, Lucas A, McFadden G. 2003. Poxviruses and immune evasion. Annu. Rev. Immunol. 21:377-423.
12. Smith GL. 1993. Vaccinia virus glycoproteins and immune evasion. J. Gen. Virol. 74:1725-1740.
13. Buller RM, Chakrabarti S, Cooper JA, Twardzik DR, Moss B. 1988. Deletion of the vaccinia virus growth factor gene reduces virus virulence. J. Virol. 62:866-874.
14. Buller RM, Chakrabarti S, Moss B, Fredrickson T. 1988. Cell proliferative response to vaccinia virus is mediated by VGF. Virology 164:182-192.
15. McFadden G, Graham K, Barry M. 1996. New strategies of immune modulation by DNA viruses. Transplant. Proc. 28:2085-2088.
16. Blomquist MC, Hunt LT, Barker WC. 1984. Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors. Proc. Natl. Acad. Sci. U. S. A. 81:7363-7367.
17. Brown JP, Twardzik DR, Marquardt H, Todaro GJ. 1985. Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor. Nature 313:491-492.
18. Chang W, Macaulay C, Hu SL, Tam JP, McFadden G. 1990. Tumorigenic poxviruses: characterization of the expression of an epidermal growth factor related gene in Shope fibroma virus. Virology 179:926-930.
19. Chen HR, Barker WC. 1985. Similarity of vaccinia 28K, v-erb-B and EGF receptors. Nature 316:219-220.
20. da Fonseca FG, Silva RL, Marques JT, Ferreira PC, Kroon EG. 1999. The genome of cowpox virus contains a gene related to those encoding the epidermal growth factor, transforming growth factor alpha and vaccinia growth factor. Virus Genes 18:151-160.
21. Lin YZ, Ke XH, Tam JP. 1991. Synthesis and structure-activity study of myxoma virus growth factor. Biochemistry 30:3310-3314.
22. Massung RF, Liu LI, Qi J, Knight JC, Yuran TE, Kerlavage AR, Parsons JM, Venter JC, Esposito JJ. 1994. Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975. Virology 201:215-240.
23. Reisner AH. 1985. Similarity between the vaccinia virus 19K early protein and epidermal growth factor. Nature 313:801-803.
24. Twardzik DR, Brown JP, Ranchalis JE, Todaro GJ, Moss B. 1985. Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors. Proc. Natl. Acad. Sci. U. S. A. 82:5300-5304.
25. Kim M, Yang H, Kim SK, Reche PA, Tirabassi RS, Hussey RE, Chishti Y, Rheinwald JG, Morehead TJ, Zech T, Damon IK, Welsh RM, Reinherz EL. 2004. Biochemical and functional analysis of smallpox growth factor (SPGF) and anti-SPGF monoclonal antibodies J. Biol. Chem. 279: 25838-25848.
26. Ma Z, Li Q, An H, Pankonin MS, Wang J, Loeb JA. 2009. Targeting human epidermal growth factor receptor signaling with the neuregulin-s heparin-binding domain J. Biol. Chem. 284:32108-32115.
27. Mediratta S, Essani K. 1999. The replication cycle of tanapox virus in owl monkey kidney cells. Can. J. Microbiol. 45:92-96.
28. Essani K, Chalasani S, Eversole R, Beuving L, Birmingham L. 1994. Multiple anti-cytokine activities secreted from tanapox virus-infected cells. Microb. Pathog. 17:347-353.
29. Paulose M, Bennett BL, Manning AM, Essani K. 1998. Selective inhibition of TNF-alpha induced cell adhesion molecule gene expression by tanapox virus. Microb. Pathog. 25:33-41.
30. Brunetti CR, Paulose-Murphy M, Singh R, Qin J, Barrett JW, Tardivel A, Schneider P, Essani K, McFadden G. 2003. A secreted high-affinity inhibitor of human TNF from Tanapox virus. Proc. Natl. Acad. Sci. U. S. A. 100:4831-4836.
31. Nazarian SH, Barrett JW, Frace AM, Olsen-Rasmussen M, Khristova M, Shaban M, Neering S, Li Y, Damon IK, Esposito JJ, Essani K, McFadden G. 2007. Comparative genetic analysis of genomic DNA sequences of two human isolates of tanapox virus. Virus Res. 129:11-25.
32. Lee HJ, Essani K, Smith GL. 2001. The genome sequence of Yaba-like disease virus, a yatapoxvirus. Virology 281:170-192.
33. Tulman ER, Afonso CL, Lu Z, Zsak L, Kutish GF, Rock DL. 2001. Genome of lumpy skin disease virus. J. Virol. 75:7122-7130.
34. Tulman ER, Afonso CL, Lu Z, Zsak L, Sur JH, Sandybaev NT, Kerembekova UZ, Zaitsev VL, Kutish GF, Rock DL. 2002. The genomes of sheeppox and goatpox viruses. J. Virol. 76:6054-6061.
35. Loeb JA, Fischbach GD. 1995. ARIA can be released from extracellular matrix through cleavage of a heparin-binding domain. J. Cell Biol. 130: 127-135.
36. Meier T, Masciulli F, Moore C, Schoumacher F, Eppenberger U, Denzer AJ, Jones G, Brenner HR. 1998. Agrin can mediate acetylcholine receptor gene expression in muscle by aggregation of muscle-derived neuregulins. J. Cell Biol. 141:715-726.
37. Fromm JR, Hileman RE, Caldwell EE, Weiler JM, Linhardt RJ. 1997. Pattern and spacing of basic amino acids in heparin binding sites. Arch. Biochem. Biophys. 343:92-100.
38. Goishi K, Higashiyama S, Klagsbrun M, Nakano N, Umata T, Ishikawa M, Mekada E, Taniguchi N. 1995. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity Mol. Biol. Cell 6:967-980.
39. Dong J, Wiley HS. 2000. Trafficking and proteolytic release of epidermal growth factor receptor ligands are modulated by their membraneanchoring domains J. Biol. Chem. 275:557-564.
40. Lin YZ, Ke XH, Tam JP. 1990. Growth inhibition by vaccinia virus growth factor. J. Biol. Chem. 265:18884-18890.
41. Esper RM, Pankonin MS, Loeb JA. 2006. Neuregulins: versatile growth and differentiation factors in nervous system development and human disease. Brain Res. Rev. 51:161-175.
42. Li Q, Loeb JA. 2001. Neuregulin-heparan-sulfate proteoglycan interactions produce sustained erbB receptor activation required for the induction of acetylcholine receptors in muscle. J. Biol. Chem. 276:38068-38075.
43. Russell KS, Stern DF, Polverini PJ, Bender JR. 1999. Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis Am. J. Physiol. 277:H2205-H2211.
44. Brunetti CR, Amano H, Ueda Y, Qin J, Miyamura T, Suzuki T, Li X, Barrett JW, McFadden G. 2003. Complete genomic sequence and comparative analysis of the tumorigenic poxvirus Yaba monkey tumor virus J. Virol. 77:13335-13347.
45. Espana C. 1971. A pox disease of monkeys transmissible to man, p 694-708. In Goldsmith EI, Moor-Jankowski J (ed), Medical primatology. Karger, Basel, Switzerland.
46. Hudziak RM, Lewis GD, Shalaby MR, Eessalu TE, Aggarwal BB, Ullrich A, Shepard HM. 1988. Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells Proc. Natl. Acad. Sci. U. S. A. 85: 5102-5106
47. Kalthoff H, Roeder C, Gieseking J, Humburg I, Schmiegel W. 1993. Inverse regulation of human ERBB2 and epidermal growth factor receptors by tumor necrosis factor alpha Proc. Natl. Acad. Sci. U. S. A. 90:8972-8976.
48. Falls DL, Rosen KM, Corfas G, Lane WS, Fischbach GD. 1993. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell 72:801-815.
49. Downie AW, Taylor-Robinson CH, Caunt AE, Nelson GS, Manson- Bahr PE, Matthews TC. 1971. Tanapox: a new disease caused by a pox virus. Br. Med. J. 1:363-368.